The National Advisory Committee on Sexually Transmitted and Blood-Borne Infections (NAC-STBBI) Statement: Chlamydia and Gonorrhea screening recommendations for non-pregnant adults and adolescents
NACI / Public Health Agency of Canada (STBBI) · 2026 · Europe
Source and licence
- Authors
- Housne Begum, Dominique Basque, Holly Sullivan et al.
- Title
- The National Advisory Committee on Sexually Transmitted and Blood-Borne Infections (NAC-STBBI) Statement: Chlamydia and Gonorrhea screening recommendations for non-pregnant adults and adolescents
- Journal
- Canada Communicable Disease Report, 2026
- Licence
- CC BY 4.0
- Changes
- Verbatim excerpts; formatting adapted
Full text retrieved 2026-10-27 from Europe PMC · PMC13268405
Licence statement of the original publication
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY) 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.
Open the original publication →Full text on Europe PMC
Recommendations
Verbatim, with grade of recommendation or strength of consensus where given.
Recommendations
- Abbreviations: CT, Chlamydia trachomatis; NAC-STBBI, National Advisory Committee on Sexually Transmitted and Blood-Borne Infections; NG, Neisseria gonorrhoeae
Abstract
Background: The National Advisory Committee on Sexually Transmitted and Blood-Borne Infections (NAC-STBBI) undertook a review to adopt, or adapt, the 2021 recommendation for chlamydia and gonorrhea screening issued by the Canadian Task Force on Preventive Health Care (CTFPHC).
Methods: The NAC-STBBI adapted the guideline following the 2014 World Health Organization (WHO) handbook. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) and GRADE-ADOLOPMENT methods were also applied to determine the certainty of evidence and strength of the recommendations. The guideline question was “should any screening vs no screening/usual care/any other screening be used for non-pregnant people?”. Conflicts of interest were managed according to the Public Health Agency of Canada guidelines.
Results: An environmental scan found 17 guidelines published between 2015 and 2023. Five systematic reviews and 32 original articles were identified and included, addressing screening types, patient values, preferences, feasibility, equity and cost and cost-effectiveness of chlamydia and gonorrhea screening. The search was conducted between October 1, 2019, to May 19, 2023. The certainty of evidence was very low.
Conclusion: The NAC-STBBI suggests universal annual screening for Chlamydia trachomatis and Neisseria gonorrhoeae infections in all sexually active persons under the age of 30 years (conditional recommendation; very low-certainty evidence). The NAC-STBBI also suggests screening every three to six months for adults and adolescents with multiple sexual partners or a new partner since last tested and “opt-out” screening as frequently as every three months for high prevalence populations or communities (conditional recommendation; very low-certainty evidence).
Contents of the original publication
The section headings of the original.
- Introduction
- Methods
- Working group
- Review of the evidence
- Results
- Evidence synthesis
- Summary of the evidence
- Benefits of screening
- Harms of screening
- Patients’ preferences and values
- Making recommendations
- Recommendations
- Discussion
- Limitations
- Conclusion
A question about this guideline?
Medelix answers clinical questions from guidelines and studies – every statement with its source.
Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint